Skip to main content
The Journal of General Physiology logoLink to The Journal of General Physiology
. 2001 Nov 1;118(5):495–508. doi: 10.1085/jgp.118.5.495

Potentiation of the Cardiac L-Type Ca2+ Channel (α1C) by Dihydropyridine Agonist and Strong Depolarization Occur via Distinct Mechanisms

Christina M Wilkens a, Manfred Grabner b, Kurt G Beam a
PMCID: PMC2233833  PMID: 11696608

Abstract

A defining property of L-type Ca2+ channels is their potentiation by both 1,4-dihydropyridine agonists and strong depolarization. In contrast, non–L-type channels are potentiated by neither agonist nor depolarization, suggesting that these two processes may by linked. In this study, we have tested whether the mechanisms of agonist- and depolarization-induced potentiation in the cardiac L-type channel (α1C) are linked. We found that the mutant L-type channel GFP-α1C(TQ→YM), bearing the mutations T1066Y and Q1070M, was able to undergo depolarization-induced potentiation but not potentiation by agonist. Conversely, the chimeric channel GFP-CACC was potentiated by agonist but not by strong depolarization. These data indicate that the mechanisms of agonist- and depolarization-induced potentiation of α1C are distinct. Since neither GFP-CACC nor GFP-CCAA was potentiated significantly by depolarization, no single repeat of α1C appears to be responsible for depolarization-induced potentiation. Surprisingly, GFP-CACC displayed a low estimated open probability similar to that of the α1C, but could not support depolarization-induced potentiation, demonstrating that a relatively low open probability alone is not sufficient for depolarization-induced potentiation to occur. Thus, depolarization-induced potentiation may be a global channel property requiring participation from all four homologous repeats.

Keywords: ion channel modulation, facilitation, muscle

INTRODUCTION

Voltage-gated Ca2+ channels respond to membrane depolarization by allowing Ca2+ into the cell, and, thus, mediate a variety of cellular responses in neurons and muscle, including transmitter release, neurite outgrowth, altered gene expression, exocytosis, and muscle contraction (Reuter 1983; Hoshi and Smith 1987; Tsien et al. 1988; Tanabe et al. 1993). Thus, modification of Ca2+ influx provides an important mechanism for the regulation of many downstream Ca2+-dependent responses. One source of modification is potentiation, whereby a channel is stabilized in the open state, and intracellular Ca2+ levels are increased as a result.

L-type Ca2+ channels show a shift in gating mode in response to either strong depolarization or 1,4-dihydropyridine (DHP) agonist. After strong depolarization, the channel enters a state of higher open probability (Po) and long open times that can be detected by a number of different pulse paradigms. For example, after a strong, conditioning depolarization (e.g., +120 mV) followed by a 50–150-ms return to the holding potential, a subsequent, moderate depolarization elicits a Ca2+ channel current that is about twofold larger than that measured without the conditioning depolarization (Bourinet et al. 1994; Cens et al. 1996, Cens et al. 1998). This effect, which implies an alteration of gating that persists after channel closing, will be designated “depolarization-induced facilitation.” Both L- and non–L-type channels are also able to undergo another form of prepulse facilitation (“Ca2+/CAM-dependent facilitation”; Lee et al. 2000; Zühlke et al. 2000; DeMaria et al. 2001), which differs from depolarization-induced facilitation in that it has a bell-shaped dependence on the prepulse potential that arises from a primary dependence upon Ca2+ entry. Ca2+/CAM-dependent facilitation appears to depend specifically (Lee et al. 2000) upon the β2a subunit, and does not occur in cells expressing β1, the isoform present in the dysgenic myotubes used in our study. Unlike Ca2+/CAM-dependent facilitation, depolarization-induced facilitation may be related to another form of altered gating observed when a strong depolarization is followed immediately by repolarization to an intermediate potential (Hoshi and Smith 1987; Pietrobon and Hess 1990; Kleppisch et al. 1994). This phenomenon, referred to here as depolarization-induced potentiation, results in a mode of gating characterized at the single-channel level by high Po and long open times, which is also referred to as “mode 2” gating (Pietrobon and Hess 1990). As an indication of depolarization-induced entry into mode 2, we have measured whole-cell tail currents upon repolarization to −50 mV immediately after a strong, conditioning depolarization. With this protocol, high Po and long open times are reflected by an increased tail-current amplitude and slower rate of tail-current decay, respectively. Mode 2 gating of L-type channels is also promoted by DHP agonists (Hess et al. 1984; Nowycky et al. 1985; Hoshi and Smith 1987). Given the similarities between agonist- and depolarization-induced potentiation, it is important to know the degree to which the two processes are related.

The cardiac L-type channel, α1C, normally exhibits a low Po < 0.05 (Cachelin et al. 1983; Lew et al. 1991) and can be potentiated by both strong depolarization and DHP agonists. By contrast, the neuronal non–L-type channel, α1A, exhibits a high Po of ∼0.6 (Llinas et al. 1989) and lacks both depolarization-induced facilitation (Bourinet et al. 1994), and DHP-induced potentiation (Sather et al. 1993). These observations suggest the possibility that depolarization- and agonist-induced potentiation can only occur in channels like α1C that have an intrinsically low Po.

In an attempt to determine whether potentiation of α1C by DHP agonist and strong depolarization occurs via a common pathway, we have characterized wild-type and mutant α1C channels and chimeric channels composed of α1C and α1A sequence. The channels were fused at their amino termini to green fluorescent protein (GFP), expressed in dysgenic myotubes and examined using whole-cell patch clamp. For an α1C in which the agonist binding site was mutated (GFP-α1C(TQ→YM)), 10 μM Bay K 8644 had no significant effect on whole-cell currents, whereas depolarization-induced potentiation remained intact. A chimeric channel containing repeat II and the I-II linker of α1A sequence embedded in L-type background (GFP-CACC) could not support depolarization-induced potentiation but was potentiated by DHP agonist. Channels containing three (CACC), two (CCAA), or no (α1A) repeats of L-type sequence were not potentiated significantly by depolarization, suggesting that depolarization-induced potentiation cannot be localized to any single channel repeat. Interestingly, despite having a relatively low estimated Po comparable to that of α1C, GFP-CACC was not potentiated by depolarization, indicating that depolarization-induced potentiation must not be dependent solely on a low Po. Our results demonstrate that the mechanisms of DHP agonist- and depolarization-induced potentiation of α1C are distinct, and that depolarization-induced potentiation may be a global channel property requiring the participation of all four homology repeats.

MATERIALS AND METHODS

Construction of Chimeric and Mutant α1 cDNAs

A and C denote sequence derived from α1A (Mori et al. 1991) or α1C (Mikami et al. 1989), respectively. An asterisk indicates a restriction site introduced by PCR. The wild-type clones GFP-α1C and GFP-α1A were produced by fusing the α1 subunit of either the cardiac L-type channel (α1C) or neuronal P/Q-type channel (α1A) at the amino terminus to GFP as previously described (Grabner et al. 1998). The GFP tag has been shown not to alter any of the functional properties of the α1C and α1A subunits (Grabner et al. 1998). The clone GFP-α1C(TQ→YM) was created using overlapping PCR mutagenesis (Horton et al. 1989) to replace two residues in the IIIS5 transmembrane domain of α1C (Thr 1066 and Gln 1070), which were previously identified as essential components of the DHP binding site (Mitterdorfer et al. 1996; He et al. 1997), with the corresponding residues of α1A (Tyr 1393 and Met 1397). In brief, the SalI*-FspI fragment of α1C (nt −12C–5054C) was subcloned into the SalI and SmaI sites of the pSP72 (Promega) polylinker. Overlapping PCR using GFP-α1C as the template yielded an 816-bp amplification product (nt 2638C–3453C) carrying the point mutations, which was then cut with AflII (nt 2689) and AspI (nt 3385) and ligated into the AflII-AspI restriction sites of the pSP72 subclone. Finally, the SalI*-EcoRV fragment (nt −12C–4348C) of the subclone was ligated into GFP-α1C at the corresponding restriction sites to yield the clone GFP-α1C(TQ→YM). The α1C1A chimera GFP-CACC consisted of repeat II and the I-II linker of α1A contained an α1C background (amino acids 1–426C/352–671A/740–2171C). To produce GFP-CACC, the SalI*-EcoRV fragment of α1C (nt −12C–4348C) was ligated into the corresponding sites of the plasmid pSP72. PCR mutagenesis was used to amplify a 980-bp product of α1A sequence, containing the introduced 5′ BamHI* and 3′ EcoRI* restriction sites at nt 1039 and 2015, respectively. The amplification product was first digested with BamHI, and then partially digested with EcoRI (to avoid cutting an internal EcoRI site), and the resulting fragment was ligated into the corresponding restriction sites of the pSP72/cardiac subclone. Finally, the SalI*-EcoRV fragment from this subclone was ligated into the SalI*-EcoRV restriction sites of GFP-α1C. The chimera GFP-CCAA was composed of repeats I and II (including the II-III linker) of α1C and repeats III and IV of α1A (amino acids 1-920C/1244-2424A). To create GFP-CCAA, the HindIII*-PvuII fragment (nt 3730A–4216A) of chimera AL2 (Grabner et al. 1996) was coligated with the PvuII-BglII fragment of α1A (nt 4216A–5891A) into the corresponding restriction sites of the plasmid pSP72. Subsequently, the XhoI-HindIII* fragment (nt 1395A–2758C) of clone AL5 (Grabner et al. 1996) was ligated into the corresponding restriction sites of the subclone. The entire XhoI-BglII insert (nt 1395A–5891A) of the final subclone was ligated into the corresponding restriction sites of GFP-α1A to produce the intermediate clone GFP-ALC. The SalI*-AvrII fragment (nt −12C–759C) of GFP-α1C was coligated with the AvrII-AocI fragment (nt 759C–1752A) of AL5 into the SalI-AocI (5′ polylinker-1752A) restriction sites of GFP-ALC, yielding the subclone GFP-C/3A. Finally, the ClaI-AflII fragment (nt 256C–2689C) of α1C was ligated into the corresponding restriction sites of subclone GFP-C/3A to yield the final chimera GFP-CCAA. The integrity of all channel constructs was confirmed using automated sequence analysis (Macromolecular Resources).

Expression and Electrophysiological Analysis of Channels in Dysgenic Myotubes

1 wk after plating, primary cultures of mouse dysgenic myotubes (Adams and Beam 1989), which lack an endogenous α1S subunit (Knudson et al. 1989), were microinjected in single nuclei with cDNAs (200–600 ng/μl) encoding GFP-tagged α1 subunits. 36–52 h after injection, expressing myotubes were identified by green fluorescence and used for electrophysiology. Macroscopic Ca2+ currents were measured using the whole-cell patch-clamp method (Hamill et al. 1981). Whole-cell patch pipettes of borosilicate glass had resistances of 1.5–2.0 MΩ when filled with an internal solution containing 140 mM cesium aspartate, 10 mM Cs2EGTA, 5 mM MgCl2, and 10 mM HEPES, pH 7.4 with CsOH. The external bath solution contained 10 mM CaCl2, 145 mM TEA-Cl, and 10 mM HEPES, pH 7.4 with TEA-OH, plus 3 μM tetrodotoxin. Test currents were obtained by stepping from a holding potential of −80 to −30 mV for 1 s (to inactivate endogenous T-type Ca2+ current; Adams et al. 1990), to −50 mV for 30–50 ms, to the test potential for 200 ms, to −50 mV for 125 ms, and back to −80 mV. Test currents were corrected for linear components of leak and capacitative currents by digitally scaling and subtracting the average of 10 preceding control currents elicited by hyperpolarizing steps (20–40 mV in amplitude) applied from the holding potential. Data were included only for cells in which the maximum voltage error (calculated by the product of peak inward current and compensated series resistance) was ≤10 mV. Except for tail currents, data were sampled at 1 kHz. Tail currents, elicited by repolarizing to −50 mV for 125 ms, were recorded with fast sampling (10 kHz). Tail-current amplitude (Itail) was measured 0.5 ms after the onset of the repolarization from the test pulse to −50 mV. The rate of tail-current decay (τdeact) was measured by fitting tail currents with a single exponential function. Maximal Ca2+ conductance (Gmax) and half-maximal activation potential (V1/2) were calculated by fitting peak inward current values with the equation:

graphic file with name M1.gif 1

where I is the peak inward Ca2+ current measured at the test potential (V), Vrev is the reversal potential, and kG is a slope factor. The values of Gmax and Vrev were used to calculate normalized conductance as a function of voltage (see Fig. 1 A and 4 C) according to the equation: G (V) = I/[Gmax · (V − Vrev)].

Figure 1.

Figure 1

Activation of currents produced by GFP-α1C or GFP-α1A expressed in dysgenic myotubes. (A) Representative Ca2+ currents elicited by 200-ms depolarizing steps to the indicated test potentials from a holding potential of −80 mV, followed by repolarization to −50 mV. Putative membrane topology for each GFP-tagged channel construct is indicated, where dark gray and light gray represent α1C and α1A sequence, respectively. (B) Average (± SEM) conductance versus voltage relationships for GFP-α1C (circles; n = 9) and GFP-α1A (inverted triangles; n = 10). The smooth curves represent best fits of the expression 1/{1 + exp [−(V − V1/2)/kG]}, which yielded the following values: for GFP-α1C, V1/2 = 8 mV, kG = 7.3 mV; and for GFP-α1A, V1/2 = 19 mV, kG = 5.1 mV.

Maximum immobilization-resistant charge movement (Qmax) was measured, after the addition of 0.5 mM Cd2+ and 0.1 mM La3+ to the bath, by integration of Qon for a 15-ms test pulse (exponentially rounded with a time constant of 100 μs) to +40 mV. Maximum channel Po was calculated from the average, measured values of Inline graphic and Inline graphic according to the equation:

graphic file with name M4.gif 2

where Inline graphic = Inline graphic - average dysgenic charge (2.5 nC/μF; Adams et al. 1990), γ is the single-channel conductance in 10 mM Ca2+, assumed to be 4 pS for α1A (Adams et al. 1994), 5.8 pS for α1C (Gollasch et al. 1992), or an average of the two (4.9 pS) for chimeras CACC and CCAA, q is the assumed single-channel gating charge (9 e; Noceti et al. 1996), F is Faraday's constant (96,487 C/mol) and A is Avogadro's number (6.023 × 1023 e/mol).

Several different measures were used to quantify potentiation. For the DHP agonist (±)Bay K 8644, one measure was the ratio Inline graphic, where the numerator and denominator represent the peak currents elicited by depolarizing test pulses in the presence or absence of drug, respectively. Inline graphic was usually elicited by a Vtest of approximately +20–30 mV, and Inline graphic for a Vtest 20–30 mV more hyperpolarized. Agonist-induced potentiation was also measured by means of the ratios Inline graphic and Inline graphic, where the tail current was produced by repolarizing to −50 mV from a Vtest of +40 mV. Depolarization-induced potentiation was quantified by the ratios Inline graphic and Inline graphic, where the numerator and denominator were determined from tail currents produced by repolarization to −50 mV after a Vtest of +90–110 mV or +40 mV, respectively.

Statistical Analysis

Statistical significance was assessed using one-way analysis of variance (ANOVA) and SAS software (version 8). All data are presented as mean ± SEM.

RESULTS

α1C Is Potentiated by DHP Agonist and Strong Depolarization while α1A Is Potentiated by Neither

Fig. 1 A illustrates representative whole-cell Ca2+ currents elicited by depolarizing dysgenic myotubes expressing either GFP-α1C or GFP-α1A to the indicated potentials, followed by repolarization to −50 mV. Based upon steady-state activation calculated from peak currents during the test depolarizations (Fig. 1 B), both channels were fully activated by test pulses to +40 mV and above. Consistent with this, the tail currents for GFP-α1A had a similar amplitude and time course after the depolarizations to either +40 or +60 mV (Fig. 1 A). However, for GFP-α1C, the tail current after the +60-mV depolarization was larger and decayed more slowly than the tail after the +40-mV step. This behavior is an indication that strong depolarization caused α1C channels to enter a mode of gating having longer open times and increased Po.

Fig. 2 compares currents produced by GFP-α1C and GFP-α1A before and after exposure to 10 μM Bay K 8644. For GFP-α1A, application of Bay K 8644 had little effect on either the current elicited by a test depolarization to +20 mV or on the tail current after repolarization (Fig. 2 A). Likewise, the average, peak current versus voltage relationship for GFP-α1A was not significantly (P > 0.1) affected by the agonist (Fig. 2 B). By contrast, Bay K 8644 caused a hyperpolarizing shift in the test potential evoking maximum inward current for GFP-α1C, together with a substantial increase in the magnitude of this current. In addition to affecting the peak current, Bay K 8644 also caused an approximately threefold increase in tail-current amplitude (Itail) and in the time constant of tail-current deactivation (τdeact) for GFP-α1C (Fig. 2 A and Table ). Overall, the effects of Bay K 8644 on GFP-α1C tail currents qualitatively resemble those of strong depolarization (compare Fig. 1 A and 2 A).

Figure 2.

Figure 2

Dihydropyridine agonist potentiates GFP-α1C but not GFP-α1A. (A) Peak Ca2+ currents from GFP-α1C (top) or GFP-α1A (bottom) elicited by 200-ms depolarizations to the indicated test potentials in the absence (control) and presence (+Bay K) of 10 μM Bay K 8644. (B) Average current versus voltage relationships for GFP-α1C (circles; n = 5) and GFP-α1A (inverted triangles; n = 7) in the absence (open symbols) or presence (closed symbols) of 10 μM Bay K 8644. The smooth curves represent best fits of to the average data resulting in the values (control/+Bay K): for GFP-α1C, Gmax = 337 nS/nF/620 nS/nF, V1/2 = 4 mV/−22 mV, Vrev = 93 mV/81 mV, kG = 7 mV/2 mV; and for GFP-α1A, Gmax = 228 nS/nF/225 nS/nF, V1/2 = 18 mV/11 mV, Vrev = 88 mV/91 mV, kG = 7 mV/8 mV.

Table 1.

Parameters of DHP Agonist- and Depolarization-induced Potentiation

GFP-α1C GFP-α1C(TQ→YM) GFP-CACC GFP-CCAA GFP-α1A
Depolarization-induced potentiation of Itail 1.9-fold ± 0.3 (8) 2.5-fold ± 0.3 (11) 1.3-fold ± 0.1 (8) 1.1-fold ± 0.3 (7) 0.9-fold ± 0.1 (8)
Depolarization-induced potentiation of τdeact 2.6-fold ± 0.8 (5) 2.7-fold ± 0.3 (8) 1.2-fold ± 0.1 (8) 1.0-fold ± 0.1 (7) 0.9-fold ± 0.1 (6)
Bay K-induced potentiation of Imax 2.7-fold ± 0.2 (5) 0.9-fold ± 0.1 (7) 3.4-fold ± 0.9 (5) 1.0-fold ± 0.1 (9) 1.1-fold ± 0.1 (7)
Bay K-induced activation shift (V1/2; mV) −24.9 ± 4.1 (5) −3.3 ± 4.2 (6) −15.7 ± 5.4 (5) −3.0 ± 0.9 (9) −3.9 ± 1.2 (6)
Bay K-induced potentiation of Itail 3.3-fold ± 0.6 (5) 0.9-fold ± 0.1 (7) 6.2-fold ± 3.7 (5) 1.3-fold ± 0.4 (9) 1.2-fold ± 0.1 (6)
Bay K-induced potentiation of τdeact 2.9-fold ± 0.5 (5) 1.2-fold ± 0.1 (7) 3.0-fold ± 0.9 (5) 1.1-fold ± 0.1 (9) 1.2-fold ± 0.1 (6)

Itail and τdeact were determined as the amplitude (0.5 ms after repolarization) and time constant of decay (determined by fit of a single exponential) of tail currents produced by repolarization to −50 mV. Depolarization-induced potentiation was quantified as the ratios (Inline graphic) or (Inline graphic), where the superscripts indicate the test potential before repolarization. The effect of 10 μM Bay K 8644 was quantified in terms of four parameters: the ratio of maximum currents (Inline graphic); the average shift in the voltage for half-maximal activation (Inline graphic); and the ratio of the values of Itail (Inline graphic) and τdeact (Inline graphic) after a test to +40 mV. All data are presented as mean ± SEM, with the numbers in parentheses indicating the number of cells tested.

Fig. 3 illustrates a more detailed characterization of tail currents in cells expressing GFP-α1C or GFP-α1A. Fig. 3 A shows the standard protocol for quantifying depolarization-induced potentiation, which was determined as the ratio of either Itail or τdeact for a tail current after a Vtest of +90 mV, to the corresponding values for a tail current after a Vtest of +40 mV. By both measures, GFP-α1C showed substantial depolarization-induced potentiation, whereas GFP-α1A did not (Fig. 3 A and Table ). Fig. 3 B illustrates the dependence of Itail on prior test potentials ranging from −40 to +80 mV. For GFP-α1A, Itail reached a maximum after a Vtest of +30 mV, in good agreement with the conductance versus voltage curve calculated from peak currents (Fig. 1 B). For still stronger depolarizations, Itail became smaller for GFP-α1A, as expected for a channel undergoing voltage-dependent inactivation that becomes faster with stronger depolarization. In contrast to GFP-α1A, Itail for GFP-α1C increased monotonically over the entire range of test potentials. This monotonic increase differs from the saturating conductance versus voltage relationship (Fig. 1 B) and is consistent with entry into a potentiated state having high Po. This monotonic voltage dependence also suggests that depolarization-induced potentiation is not dependent upon Ca2+ entry during the prepulse. The application of 10 μM Bay K 8644 caused a still further increase in Po, which is indicated by a substantial increase in Itail for GFP-α1C at any given test potential (Fig. 3 B). In the presence of agonist, Itail was still increased by stronger test depolarizations, up to at least +70 mV. Table summarizes the effects of DHP agonist and strong depolarization on tail currents for GFP-α1C and GFP-α1A.

Figure 3.

Figure 3

Depolarization-induced potentiation of GFP-α1C but not of GFP-α1A. (A) Tail currents were elicited by depolarization from the holding potential (−80 mV) to −30 mV for 1 s (to inactivate endogenous T-type current; Adams et al. 1990), a 30–50-ms repolarization to −50 mV, a 200-ms test depolarization (Vtest) to varying potentials, followed by repolarization to −50 mV. Whole-cell currents are shown for GFP-α1C (top) and GFP-α1A (bottom) for test depolarizations of +40 and +90 mV. Note that for GFP-α1C, the tail current after the Vtest of +90 mV was larger and decayed more slowly than that after the Vtest of +40 mV, whereas the tail currents for GFP-α1A differed little for a Vtest of +40 or +90 mV. The 50-ms time calibration applies to the currents during the test depolarization and the 5-ms calibration to the tail currents at −50 mV. (B) Relationship of tail-current amplitude (Itail) at −50 mV to test pulse potential (Vtest) for cells expressing GFP-α1C (circles; n = 5) or GFP-α1A (inverted triangles; n = 7) in the absence (open symbols) or presence (closed symbols) of 10 μM Bay K 8644. The amplitude of the tail currents for GFP-α1C grew larger with increasing Vtest over the entire range of potentials examined, whereas those for GFP-α1A appeared to saturate with peak current.

Mutation of T1066 and Q1070 of α1C Eliminates Agonist- but Not Depolarization-induced Potentiation

The observation that GFP-α1C is potentiated by both agonist and strong depolarization, whereas GFP-α1A is potentiated by neither, raises the possibility that agonist- and depolarization-induced potentiation are linked. As one test of this hypothesis, we created GFP-α1C(TQ→YM), in which two residues of IIIS5 that are critical for the DHP sensitivity of α1C (Mitterdorfer et al. 1996; He et al. 1997) were converted to the corresponding residues of α1A. Currents produced by GFP-α1C(TQ→YM) were not affected by the addition of 10 μM Bay K 8644 (Fig. 4 A), whereas depolarization-induced potentiation was intact (Fig. 4 B). In particular, tail currents were larger and decayed more slowly after a Vtest of +90 mV compared with a Vtest of +40 mV (Fig. 4 B, top) and the tail-current amplitude increased monotonically as a function of test potential (Fig. 4 B, bottom). On average, GFP-α1C(TQ→YM) was quantitatively similar to GFP-α1C with respect to depolarization-induced potentiation, but was indistinguishable from GFP-α1A in the lack of agonist-induced potentiation (Table ). Interestingly, mutation of T1066 and Q1070 in the IIIS5 transmembrane segment of α1C resulted in a decreased steepness, and positive shift, of the steady-state activation curve in comparison to GFP-α1C (Fig. 4 C), indicating that these residues can affect activation gating. Taken together, the data of Fig. 4 demonstrate that depolarization-induced potentiation still occurs in a mutant α1C lacking a response to DHP agonist.

Figure 4.

Figure 4

Mutation of the agonist binding site of GFP-α1C abolishes potentiation by agonist (A) but not by depolarization (B). (A, top) Whole-cell currents from a myotube expressing GFP-α1C(TQ→YM) in the absence (control) or presence (+Bay K) of 10 μM Bay K 8644. (A, bottom) Average peak current versus voltage relationship for GFP-α1C(TQ→YM) in the absence (open squares; n = 7) or presence (closed squares; n = 7) of 10 μM Bay K 8644. The smooth curves represent best fits of the data with , yielding the values (control/+Bay K): Gmax = 287 nS/nF/218 nS/nF, V1/2 = 9 mV/1 mV, Vrev = 103 mV/104 mV, kG = 10 mV/13 mV. (B, top) Whole-cell currents for GFP-α1C(TQ→YM) measured for test pulses to +40 or +90 mV, followed by repolarization to −50 mV; for clarity, the tail currents at −50 mV are shown on a faster time scale (5-ms calibration bar). (B, bottom) Tail-current amplitudes at −50 mV as a function of a prior test potential for GFP-α1C(TQ→YM) (open squares; n = 11). (C) Conductance versus voltage relationships for GFP-α1C (circles; n = 9) and GFP-α1C(TQ→YM) (squares; n = 10). The smooth lines represent best fits of the data with the expression: 1/{1 + exp [−(V − V1/2)/kG]}, yielding the following values: for GFP-α1C, V1/2 = 9 mV, kG = 7 mV; and for GFP-α1C(TQ→YM), V1/2 = 20 mV, kG = 16 mV.

Agonist-induced Potentiation Persists in the Absence of Depolarization-induced Potentiation

In an attempt to determine whether a single repeat of α1C is sufficient to allow depolarization-induced potentiation, we constructed the chimeras GFP-CACC and GFP-CCAA and tested them for agonist- and depolarization-induced potentiation (Fig. 5). GFP-CACC consists of repeat II and the I-II linker of α1A in an otherwise α1C background (Fig. 5A and Fig. C), and thus contains an intact DHP agonist binding site (Grabner et al. 1996; Hockerman et al. 1997; Ito et al. 1997; Sinnegger et al. 1997). As shown in Fig. 5 A, 10 μM Bay K 8644 potentiated maximum inward current in cells expressing GFP-CACC and caused a leftward shift in the peak current versus voltage relationship. Quantitatively, both effects were similar to those of 10 μM Bay K 8644 on GFP-α1C (Table ). However, this chimera failed to show the large depolarization-induced potentiation characteristic of either GFP-α1C or GFP-α1C(TQ→YM) (Table ; also, compare Fig. 5 C with Fig. 3 B and 4 B). Thus agonist-induced potentiation can be present in a channel construct that lacks significant depolarization-induced potentiation. The chimera GFP-CCAA (Fig. 5B and Fig. D) consists of the first two repeats and the II-III linker of α1C fused to repeats III and IV of α1A. GFP-CCAA lacked both agonist- and depolarization-induced potentiation (Fig. 5B and Fig. D, and Table ). Fig. 6 summarizes the effects of strong depolarization and DHP agonist on the constructs GFP-α1C, GFP-α1C(TQ→YM), GFP-CACC, and GFP-α1A. The asterisks indicate a significant (P < 0.05) difference from onefold (where onefold indicates a lack of potentiation). Fig. 6 demonstrates that depolarization-induced potentiation can persist in the absence of potentiation by agonist (i.e., GFP-α1C(TQ→YM)), and potentiation by agonist can occur in the absence of depolarization-induced potentiation (i.e., GFP-CACC); therefore, the two processes likely occur via distinct mechanisms.

Figure 5.

Figure 5

Presence or absence of potentiation by agonist or depolarization for chimeric channels. The chimeric channels GFP-CACC and GFP-CCAA are represented schematically with dark gray and light gray representing regions derived from α1C and α1A, respectively. (A and B) Average peak current versus voltage relationships for cells expressing GFP-CACC (diamonds; n = 5) or GFP-CCAA (triangles; n = 7), in the absence (open symbols) or presence (closed symbols) of 10 μM Bay K 8644. The smooth lines represent best fits of to the average data, yielding the following values (control/+Bay K): for GFP-CACC, Gmax = 111 nS/nF/283 nS/nF, V1/2 = 0 mV/−14 mV, Vrev = 86 mV/73 mV, kG = 6 mV/5 mV; and for GFP-CCAA, Gmax = 142 nS/nF/133 nS/nF, V1/2 = 17 mV/15 mV, Vrev = 84 mV/86 mV, kG = 4 mV/7 mV. (C and D) Average values of tail-current amplitudes as a function of test potential for cells expressing GFP-CACC (open diamonds; n = 8) or GFP-CCAA (open triangles; n = 7). Insets illustrate superimposed currents elicited by test depolarizations to +90 or +40 mV, with the horizontal scale bars corresponding to 5 ms for the tail currents and 50 ms during the test depolarization. The vertical scale bars correspond to either 5 pA/pF (C) or 1 pA/pF (D). GFP-CACC was potentiated by agonist but not depolarization, whereas GFP-CCAA was potentiated by neither.

Figure 6.

Figure 6

Agonist- and depolarization-induced potentiation occur via distinct mechanisms. (A) Average potentiation of tail-current amplitude by strong depolarization (Inline graphic, white bars) or 10 μM Bay K 8644 (Inline graphic, hatched bars) for the indicated constructs expressed in dysgenic myotubes. (B) Average potentiation of τdeact by strong depolarization (Inline graphic, white bars) or 10 μM Bay K 8644 (Inline graphic, hatched bars) for the indicated constructs expressed in dysgenic myotubes. The dashed lines at onefold indicate no potentiation. Asterisks indicate a significant difference (P < 0.05) from 1. The number of cells tested in each group ranged from five to eight.

No Single Repeat of α1C Is Sufficient for Depolarization-induced Potentiation

Fig. 7 shows that in terms of both amplitude of tail currents (A) and τdeact (B), the chimeras GFP-CACC and GFP-CCAA, like α1A, lacked depolarization-induced potentiation. Because GFP-CACC lacked depolarization-induced potentiation, none of the three cardiac repeats contained in this construct (i.e., I, III, and IV) appears to be sufficient, individually or in concert, to mediate this process. In addition, because GFP-CCAA contains a cardiac repeat II and lacked depolarization-induced potentiation, a cardiac repeat II does not appear to be sufficient, either alone or in combination with repeat I. In conclusion, no single repeat of α1C seems to be sufficient for depolarization-induced potentiation, which may instead represent a more global property. Several combinations of multiple repeats are tested by the chimeras examined in this paper, and others cannot be tested because not all possible combinations of repeats of L-type and non–L-type sequence produce functional channels (Grabner et al. 1996; Spaetgens and Zamponi 1999).

Figure 7.

Figure 7

Depolarization-induced potentiation cannot be localized to any single channel repeat. Average depolarization-induced potentiation of tail-current amplitude (A), or tail-current deactivation (B) for the indicated constructs. Channel open probability (Po) for the same constructs (C) was estimated according to (as described in materials and methods). Values for Po were as follows: α1C = 0.01, CACC = 0.03, CCAA = 0.14, and α1A = 0.21. The dashed lines at onefold indicate no potentiation. The number of cells tested in each group ranged from five to eight. Asterisks indicate a significant difference (P < 0.05) from 1.

Because potentiation is defined by a shift into a gating mode of substantially increased Po, it seems likely that potentiation could not occur in a channel already having a relatively high Po. Therefore, it is of interest to know whether the lack of depolarization-induced potentiation in GFP-CACC and GFP-CCAA is a consequence of an already high Po. We used (materials and methods) to estimate Po for GFP-α1C, GFP-CACC, GFP-CCAA, and GFP-α1A from measured values of Gmax and Qmax. The values estimated by this approach for both GFP-α1C and GFP-α1A (Table ) are in reasonable agreement with values determined from single-channel measurements for α1C (<0.05; Cachelin et al. 1983; Lew et al. 1991) or α1A (0.6; Llinas et al. 1989). Moreover, as shown in Fig. 7 C, the estimated Po for GFP-α1A was about 30-fold higher than for GFP-α1C. The estimated Po for GFP-CCAA was similar to that of GFP-α1A, but estimated Po for GFP-CACC was much closer to that of GFP-α1C (Fig. 7 C and Table ). The absence of depolarization-induced potentiation for GFP-CACC indicates that a low Po alone is not a sufficient condition for this process to occur. The lack of depolarization-induced potentiation for GFP-CACC is even more striking given that this construct can be strongly potentiated by agonist.

Table 2.

Properties of Wild-type and Chimeric Channels Expressed in Dysgenic Myotubes

Units GFP-α1C GFP-CACC GFP-CCAA GFP-α1A
Imax pA/pF 35.2 ± 4.1 (19) 7.0 ± 1.1 (16) 4.8 ± 1.1 (18) 22.3 ± 4.8(16)
V1/2 mV +6.0 ± 0.6 (10) +7.6 ± 2.2 (16) +15.3 ± 1.5(17) +18.1 ± 1.7(12)
Gmax nS/nF 436.4 ± 76.1 (13) 118.5 ± 13.8 (16) 105.0 ± 20.7 (18) 352.0 ± 61.9 (16)
Qmax nC/μF 20.9 ± 2.7 (6) 3.0 ± 0.5 (11) 2.9 ± 0.4 (10) 3.2 ± 0.3(7)
Po 0.007 (5) 0.028 (6) 0.144 (6) 0.212(7)

Imax is the peak inward current determined by measuring Ca2+ currents elicited with 200-ms test depolarizations ranging from −40 to +100 mV. Values for half-maximal activation potential (V1/2) and maximal conductance (Gmax) were determined by fitting peak Ca2+ currents according to . Maximum immobilization-resistant charge movement (Qmax) was measured by integration of the “On” gating current for a 15-ms step to +40 mV. Open channel probability (Po) was estimated using and measured values of Inline graphic and Inline graphic (as described in materials and methods). All data are presented as mean ± SEM, with numbers in parentheses indicating the number of cells tested.

DISCUSSION

In the present study, we have examined DHP- and depolarization-induced potentiation of L-type Ca2+ channels by expressing GFP-tagged cardiac (α1C) and neuronal (α1A) α1 subunits in dysgenic myotubes. For GFP-α1C, both strong depolarization and agonist (10 μM Bay K 8644) caused tail currents to become larger and to decay more slowly, whereas tail currents for GFP-α1A were not affected by either manipulation. Introduction of two point mutations (T1066Y and Q1070M) into GFP-α1C abolished potentiation by agonist without any evident effect on potentiation by depolarization. Conversely, agonist but not depolarization caused potentiation of a chimera of α1C and α1A (GFP-CACC). Because depolarization-induced potentiation was absent for both GFP-CACC and the chimera GFP-CCAA, it appears that no single repeat of α1C can be responsible for this process. GFP-CACC displayed a relatively low estimated Po, quite similar to that of GFP-α1C, whereas the estimated Po for both GFP-CCAA and GFP-α1A was much higher. Therefore, a channel that displays a low Po (and is potentiated by agonist) can fail to be potentiated by depolarization.

Independent Pathways for Potentiation by DHP Agonist and Depolarization

Unitary records of L-type Ca2+ channels have been described as having three modes of gating upon depolarization: mode 0 (null sweeps); mode 1 characterized by brief openings (<1 ms) in bursts; and mode 2 defined by longer openings and high Po (Hess et al. 1984). Mode 1 is the predominant mode accessed during moderate depolarizations from the holding potential in the absence of DHP agonist, whereas mode 2 is promoted by the presence of agonist (Hess et al. 1984). Strong depolarization also promotes long openings of L-type channels in both chromaffin (Hoshi and Smith 1987) and cardiac cells (Pietrobon and Hess 1990). Because we have found that potentiation by either agonist or depolarization can be eliminated without a quantitative reduction in the effect of the other, it appears that these two processes occur via distinct pathways. In addition, we have used a concentration of agonist (10 μM Bay K 8644) that is supramaximal (Kokubun and Reuter 1984); therefore, the additional potentiation of tail currents by depolarization in the presence of the agonist also strongly suggests the presence of two independent pathways leading to a potentiated open state. Several other labs have likewise concluded from the additivity of the effects of depolarization and agonist, that these two stimuli cause an increased Po by distinct pathways (Bourinet et al. 1994; Parri and Lansman 1996). Moreover, single-channel measurements show both different open times and first latencies depending on whether potentiation is induced by depolarization or agonist (Hoshi and Smith 1987). In combination, these data suggest not only that mode 2 gating can be accessed by multiple pathways, but also that mode 2 consists of more than one potentiated open state.

Bay K 8644 is well-known to shift activation in the hyperpolarizing direction (Fig. 2; Hess et al. 1984; Sanguinetti et al. 1986), indicating that it shifts equilibrium towards the open state of the channel. We have shown here that mutation of residues T1066 and Q1070 in the IIIS5 transmembrane domain of α1C not only ablates the response to agonist, but also shifts the voltage dependence of activation oppositely, in the depolarizing direction. On this basis, one could hypothesize that Bay K 8644 promotes a conformation of these two residues that stabilizes open states of the channel, and mutation of these residues destabilizes this conformation.

Role of Accessory Subunits and of Phosphorylation in Depolarization-induced Potentiation

The accessory β subunit has been shown to influence modal gating of α1C. In particular, comparison of α1C expressed with or without the β2a subunit showed that β2a increased both open times and the proportion of long openings (Costantin et al. 1998). β subunits also have been reported to affect depolarization-induced facilitation, which may be mechanistically related to depolarization-induced potentiation (introduction). Specifically, depolarization-induced facilitation was found to occur when α1C was coexpressed with the β1, β3, or β4 subunits (Bourinet et al. 1994; Cens et al. 1998), but not with β2a (Cens et al. 1996), raising the possibility that the β subunit plays a direct role in depolarization-induced facilitation of α1C, and perhaps in potentiation as well. However, others have found that depolarization-induced potentiation of the smooth muscle α1C occurs in the absence of any β subunit (Kleppisch et al. 1994). Whatever the exact role of the β subunit, our results demonstrate that depolarization-induced potentiation is strongly influenced by the α1 subunit itself, because all of the α1 constructs examined in this study have a conserved “alpha interaction domain” (site of β subunit binding; Pragnell et al. 1994) and were expressed with a common β subunit (β1a, which is endogenous to skeletal muscle; Ruth et al. 1989).

Evidence has been presented that PKA-dependent phosphorylation occurring during depolarizing prepulses is necessary for depolarization-induced facilitation of α1S (Sculptoreanu et al. 1993b; Johnson et al. 1994), the cardiac α1C (Sculptoreanu et al. 1993a), and the neuronal α1C (Sculptoreanu et al. 1995). Evidence also has been presented that phosphorylation during depolarization is not involved in depolarization-induced facilitation of the neuronal α1C, although basal phosphorylation may be required (Bourinet et al. 1994). If phosphorylation is required (either basal or voltage-dependent), then it seems unlikely to involve phosphorylation of α1C directly because truncation of the consensus PKA sites (Gao et al. 1997) of the α1C carboxyl tail does not eliminate depolarization-induced facilitation (Cens et al. 1998). Consistent with this result, we found that depolarization-induced potentiation does not occur for GFP-CACC even though it contains all the consensus PKA sites of α1C.

Structural Determinants of Depolarization-induced Potentiation and Low Po

As discussed above, brief openings predominate during activation of α1C by modest depolarizations applied from a negative holding potential (mode 1 gating). The conformational changes responsible for activation of these brief openings occur rapidly (macroscopic activation occurs with a time constant of several ms at +30 mV; Tanabe et al. 1991). Depolarization-induced entry into mode 2 occurs on a significantly slower time scale (with a time constant of several hundred ms at +30 mV) and over a much more positive voltage range (Pietrobon and Hess 1990). Despite these differences, depolarization-induced potentiation resembles mode 1 activation in being strongly voltage-dependent: based on two-state Boltzmann fits, the effective gating charge is 2.5 for depolarization-induced potentiation and 3.2 for mode 1 activation (Pietrobon and Hess 1990). Thus, the question arises as to the identity of the voltage sensor for depolarization-induced potentiation. One possibility is that, after undergoing the relatively rapid movements leading to mode 1 openings, the S4 segments can undergo subsequent, slower movements in response to still stronger depolarization. It is equally possible that structures other than S4 serve as voltage sensors for depolarization-induced potentiation. Because we found that neither GFP-CACC nor GFP-CCAA undergo depolarization-induced potentiation, it seems unlikely that the voltage-sensing structures for depolarization-induced potentiation are localized within a single repeat. Rather, depolarization-induced potentiation of α1C appears to require large movements of charge distributed throughout the protein.

L-type channels like α1S and α1C differ from α1A channels in that the L-type channels display agonist- and depolarization-induced potentiation, and also have a much lower Po, raising the possibility that the structural determinants of potentiation and low Po reside in similar structures. However, the chimera GFP-CACC had a relatively low Po, yet did not display significant depolarization-induced potentiation. Because the chimera GFP-CCAA displayed a high Po, the amino-terminal half of α1C (repeats I and II) does not appear to be an important determinant of low Po; instead, structural requirements for low Po may reside in the carboxyl half of the protein. Certainly, it is attractive to hypothesize that repeats III and IV are important for the intrinsic, low Po of L-type channels since these same two repeats play an essential role in agonist binding, which increases Po. A role for the carboxyl tail in determining Po is suggested by previous work showing that Po of α1C is markedly increased by partial truncation of the carboxyl tail (Wei et al. 1994).

As stated earlier, the Po of the L-type channels containing α1C (<0.05; Cachelin et al. 1983; Lew et al. 1991) is much lower than that of the neuronal channels containing α1A (0.6; Llinas et al. 1989) or α1B (0.5; Delcour and Tsien 1993). Because single-channel conductance varies less than twofold amongst these channels ([α1C] Kokobun and Reuter, 1984; [α1A] Zhang et al. 1993; [α1B] Rittenhouse and Hess 1994), the production of an equivalent macroscopic current would require a much higher density of the L-type channels. A primary role of L-type Ca2+ channels in muscle is to regulate Ca2+ movements through ryanodine receptors. For this control to be relatively tight, it may be useful to have an ∼1:1 correspondence between the plasmalemmal L-type channels and the intracellular ryanodine receptors. Perhaps this correspondence is best served by a relatively high density of low Po channels. Conversely, a high Po and relatively low channel density would be advantageous when it is critical that a cellular response be triggered by the activation of only a few channels. Important goals for future work will be to better define the structures determining the differences in Po between α1C and neuronal channels like α1A and α1B, and to identify the conformational rearrangements that occur during potentiation of L-type channels.

Acknowledgments

We thank Kathy Parsons and Lindsay Grimes for performing the tissue culture.

This work was supported by the National Institutes of Health grant NS24444 to K.G. Beam, an NIH predoctoral fellowship MH12512 to C.M. Wilkens, and by the Fonds zur Förderung der Wissenschaftlichen Forschung, Austria (J01242-GEN) to M. Grabner.

Footnotes

Abbreviations used in this paper: DHP, 1,4-dihydropyridine; GFP, green fluorescent protein; nt, nucleotide; Po, open probability.

References

  1. Adams B.A., Beam K.G. A novel Ca2+ current in dysgenic skeletal muscle. J. Gen. Physiol. 1989;94:429–444. doi: 10.1085/jgp.94.3.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams B.A., Tanabe T., Mikami A., Numa S., Beam K.G. Intramembrane charge movement restored in dysgenic skeletal muscle by injection of dihydropyridine receptor cDNAs. Nature. 1990;346:569–572. doi: 10.1038/346569a0. [DOI] [PubMed] [Google Scholar]
  3. Adams B.A., Mori Y., Kim M.S., Tanabe T., Beam K.G. Heterologous expression of BI Ca2+ channels in dysgenic skeletal muscle. J. Gen. Physiol. 1994;104:985–996. doi: 10.1085/jgp.104.5.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bourinet E., Charnet P., Tomlinson W.J., Stea A., Snutch T.P., Nargeot J. Voltage-dependent facilitation of a neuronal α1C L-type calcium channel. EMBO J. 1994;13:5032–5039. doi: 10.1002/j.1460-2075.1994.tb06832.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cachelin A.B., de Peyer J.E., Kokubun S., Reuter H. Ca2+ channel modulation by 8-bromocyclic AMP in cultured heart cells. Nature. 1983;304:462–464. doi: 10.1038/304462a0. [DOI] [PubMed] [Google Scholar]
  6. Cens T., Mangoni M.E., Richard S., Nargeot J., Charnet P. Coexpression of the β2 subunit does not induce voltage-dependent facilitation of the class C L-type Ca2+ channel. Pflügers Arch. 1996;431:771–774. [PubMed] [Google Scholar]
  7. Cens T., Restituito S., Vallentin A., Charnet P. Promotion and inhibition of L-type Ca2+ channel facilitation by distinct domains of the subunit. J. Biol. Chem. 1998;273:18308–18315. doi: 10.1074/jbc.273.29.18308. [DOI] [PubMed] [Google Scholar]
  8. Costantin J., Noceti F., Qin N., Wei X., Birnbaumer L., Stefani E. Facilitation by the β2a subunit of pore openings in cardiac Ca2+ channels. J. Physiol. 1998;507:93–103. doi: 10.1111/j.1469-7793.1998.093bu.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Delcour A.H., Tsien R.W. Altered prevalence of gating modes in neurotransmitter inhibition of N-type Ca2+ channels. Science. 1993;259:980–984. doi: 10.1126/science.8094902. [DOI] [PubMed] [Google Scholar]
  10. DeMaria C.D., Soong T.W., Alseikhan B.A., Alvania R.S., Yue D.T. Calmodulin bifurcates the local Ca2+ signal that modulates P/Q-type Ca2+ channels. Nature. 2001;411:484–489. doi: 10.1038/35078091. [DOI] [PubMed] [Google Scholar]
  11. Gao T., Yatani A., Dell'Acqua M.L., Sako H., Green S.A., Dascal N., Scott J.D., Hosey M.M. cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron. 1997;19:185–196. doi: 10.1016/s0896-6273(00)80358-x. [DOI] [PubMed] [Google Scholar]
  12. Gollasch M., Hescheler J., Quayle J.M., Patlak J.B., Nelson M.T. Single Ca2+ channel currents of arterial smooth muscle at physiological Ca2+ concentrations. Am. J. Physiol. 1992;263:C948–C952. doi: 10.1152/ajpcell.1992.263.5.C948. [DOI] [PubMed] [Google Scholar]
  13. Grabner M., Wang Z., Hering S., Striessnig J., Glossmann H. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) Ca2+ channels. Neuron. 1996;16:207–218. doi: 10.1016/s0896-6273(00)80037-9. [DOI] [PubMed] [Google Scholar]
  14. Grabner M., Dirksen R.T., Beam K.G. Tagging with green fluorescent protein reveals a distinct subcellular distribution of L-type and non-L-type Ca2+ channels expressed in dysgenic myotubes. Proc. Natl. Acad. Sci. USA. 1998;95:1903–1908. doi: 10.1073/pnas.95.4.1903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 1981;391:85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  16. He M., Bodi I., Mikala G., Schwartz A. Motif III S5 of L-type Ca2+ channels is involved in the dihydropyridine binding site. A combined radioligand binding and electrophysiological study. J. Biol. Chem. 1997;272:2629–2633. doi: 10.1074/jbc.272.5.2629. [DOI] [PubMed] [Google Scholar]
  17. Hess P., Lansman J.B., Tsien R.W. Different modes of Ca2+ channel gating behaviour favoured by dihydropyridine Ca2+ agonists and antagonists. Nature. 1984;311:538–544. doi: 10.1038/311538a0. [DOI] [PubMed] [Google Scholar]
  18. Hockerman G.H., Johnson B.D., Abbot M.R., Scheuer T., Catterall W.A. Molecular determinants of high-affinity phenylalkylamine block of L-type Ca2+ channels in transmembrane segment IIIS6 and the pore region of the α1 subunit. J. Biol. Chem. 1997;272:18759–18765. doi: 10.1074/jbc.272.30.18759. [DOI] [PubMed] [Google Scholar]
  19. Horton R.M., Hunt H.D., Ho S.N., Pullen J.K., Pease L.R. Engineering hybrid genes without the use of restriction enzymesgene splicing by overlap extension. Gene. 1989;77:61–68. doi: 10.1016/0378-1119(89)90359-4. [DOI] [PubMed] [Google Scholar]
  20. Hoshi T., Smith S.J. Large depolarization induces long openings of voltage-dependent Ca2+ channels in adrenal chromaffin cells. J. Neurosci. 1987;7:571–580. doi: 10.1523/JNEUROSCI.07-02-00571.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ito H., Klugbauer N., Hofmann F. Transfer of the high affinity dihydropyridine sensitivity from L-type to non-L-type Ca2+ channel. Mol. Pharmacol. 1997;52:735–740. doi: 10.1124/mol.52.4.735. [DOI] [PubMed] [Google Scholar]
  22. Johnson B.D., Scheuer T., Catterall W.A. Voltage-dependent potentiation of L-type Ca2+ channels in skeletal muscle cells requires anchored cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 1994;91:11492–11496. doi: 10.1073/pnas.91.24.11492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kleppisch T., Pedersen K., Strubing C., Bosse-Doenecke E., Flockerzi V., Hofmann F., Hescheler J. Double-pulse facilitation of smooth muscle α1 subunit Ca2+ channels expressed in CHO cells. EMBO J. 1994;13:2502–2507. doi: 10.1002/j.1460-2075.1994.tb06538.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Knudson C.M., Chaudhari N., Sharp A.H., Powell J.A., Beam K.G., Campbell K.P. Specific absence of the α1 subunit of the dihydropyridine receptor in mice with muscular dysgenesis. J. Biol. Chem. 1989;264:1345–1348. [PubMed] [Google Scholar]
  25. Kokubun S., Reuter H. Dihydropyridine derivatives prolong the open state of Ca2+ channels in cultured cardiac cells. Proc. Natl. Acad. Sci. USA. 1984;81:4824–4827. doi: 10.1073/pnas.81.15.4824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lee A., Scheuer T., Catterall W.A. Ca2+/calmodulin-dependent facilitation and inactivation of P/Q-type type Ca2+ channels. J. Neurosci. 2000;20:6830–6838. doi: 10.1523/JNEUROSCI.20-18-06830.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lew W.Y., Hryshko L.V., Bers D.M. Dihydropyridine receptors are primarily functional L-type Ca2+ channels in rabbit ventricular myocytes. Circ. Res. 1991;69:1139–1145. doi: 10.1161/01.res.69.4.1139. [DOI] [PubMed] [Google Scholar]
  28. Llinas R.R., Sugimori M., Cherksey B. Voltage-dependent Ca2+ conductances in mammalian neurons. The P channel. Ann. NY Acad. Sci. 1989;560:103–111. doi: 10.1111/j.1749-6632.1989.tb24084.x. [DOI] [PubMed] [Google Scholar]
  29. Mikami A., Imoto K., Tanabe T., Niidome T., Mori Y., Takeshima H., Narumiya S., Numa S. Primary structure and functional expression of the cardiac dihydropyridine-sensitive Ca2+ channel. Nature. 1989;340:230–233. doi: 10.1038/340230a0. [DOI] [PubMed] [Google Scholar]
  30. Mitterdorfer J., Wang Z., Sinnegger M.J., Hering S., Striessnig J., Grabner M., Glossmann H. Two amino acid residues in the IIIS5 segment of L-type Ca2+ channels differentially contribute to 1,4-dihydropyridine sensitivity. J. Biol. Chem. 1996;271:30330–30335. doi: 10.1074/jbc.271.48.30330. [DOI] [PubMed] [Google Scholar]
  31. Mori Y., Friedrich T., Kim M.S., Mikami A., Nakai J., Ruth P., Bosse E., Hofmann F., Flockerzi V. Primary structure and functional expression from complementary DNA of a brain Ca2+ channel. Nature. 1991;350:398–402. doi: 10.1038/350398a0. [DOI] [PubMed] [Google Scholar]
  32. Noceti F., Baldelli P., Wei X., Qin N., Toro L., Birnbaumer L., Stefani E. Effective gating charges per channel in voltage-dependent K+ and Ca2+ channels. J. Gen. Physiol. 1996;108:143–155. doi: 10.1085/jgp.108.3.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nowycky M.C., Fox A.P., Tsien R.W. Long-opening mode of gating of neuronal Ca2+ channels and its promotion by the dihydropyridine Ca2+ agonist Bay K 8644. Proc. Natl. Acad. Sci. USA. 1985;82:2178–2182. doi: 10.1073/pnas.82.7.2178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Parri H.R., Lansman J.B. Multiple components of Ca2+ channel facilitation in cerebellar granule cellsexpression of facilitation during development in culture. J. Neurosci. 1996;16:4890–4902. doi: 10.1523/JNEUROSCI.16-16-04890.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pietrobon D., Hess P. Novel mechanism of voltage-dependent gating in L-type Ca2+ channels. Nature. 1990;346:651–655. doi: 10.1038/346651a0. [DOI] [PubMed] [Google Scholar]
  36. Pragnell M., De Waard M., Mori Y., Tanabe T., Snutch T.P., Campbell K.P. Ca2+ channel β subunit binds to a conserved motif in the I-II cytoplasmic linker of the α1 subunit. Nature. 1994;368:67–70. doi: 10.1038/368067a0. [DOI] [PubMed] [Google Scholar]
  37. Reuter H. Ca2+ channel modulation by neurotransmitters, enzymes and drugs. Nature. 1983;301:569–574. doi: 10.1038/301569a0. [DOI] [PubMed] [Google Scholar]
  38. Rittenhouse A.R., Hess P. Microscopic heterogeneity in unitary N-type Ca2+ currents in rat sympathetic neurons. J. Physiol. 1994;474:87–99. doi: 10.1113/jphysiol.1994.sp020005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ruth P., Rohrkasten A., Biel M., Bosse E., Regulla S., Meyer H.E., Flockerzi V., Hofmann F. Primary structure of the β subunit of the DHP-sensitive Ca2+ channel from skeletal muscle. Science. 1989;245:1115–1118. doi: 10.1126/science.2549640. [DOI] [PubMed] [Google Scholar]
  40. Sanguinetti M.C., Krafte D.S., Kass R.S. Voltage-dependent modulation of Ca2+ channel current in heart cells by Bay K8644. J. Gen. Physiol. 1986;88:369–392. doi: 10.1085/jgp.88.3.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sather W.A., Tanabe T., Zhang J.F., Mori Y., Adams M.E., Tsien R.W. Distinctive biophysical and pharmacological properties of class A (BI) Ca2+ channel α1 subunits. Neuron. 1993;11:291–303. doi: 10.1016/0896-6273(93)90185-t. [DOI] [PubMed] [Google Scholar]
  42. Sculptoreanu A., Rotman E., Takahashi M., Scheuer T., Catterall W.A. Voltage-dependent potentiation of the activity of cardiac L-type Ca2+ channel α1 subunits due to phosphorylation by cAMP-dependent protein kinase Proc. Natl. Acad. Sci. USA. 90 1993. 10135 10139a [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sculptoreanu A., Scheuer T., Catterall W.A. Voltage-dependent potentiation of L-type Ca2+ channels due to phosphorylation by cAMP-dependent protein kinase Nature. 364 1993. 240 243b [DOI] [PubMed] [Google Scholar]
  44. Sculptoreanu A., Figourov A., De Groat W.C. Voltage-dependent potentiation of neuronal L-type Ca2+ channels due to state-dependent phosphorylation. Am. J. Physiol. 1995;269:C725–C732. doi: 10.1152/ajpcell.1995.269.3.C725. [DOI] [PubMed] [Google Scholar]
  45. Sinnegger M.J., Wang Z., Grabner M., Hering S., Striessnig J., Glossmann H., Mitterdorfer J. Nine L-type amino acids confer full 1,4-dihydropyridine sensitivity to the neuronal Ca2+ channel α1A subunitrole of L-type Met-1188. J. Biol. Chem. 1997;272:27686–27693. doi: 10.1074/jbc.272.44.27686. [DOI] [PubMed] [Google Scholar]
  46. Spaetgens R.L., Zamponi G.W. Multiple structural domains contribute to voltage-dependent inactivation of rat brain α1E Ca2+channels. J. Biol. Chem. 1999;274:22428–22436. doi: 10.1074/jbc.274.32.22428. [DOI] [PubMed] [Google Scholar]
  47. Tanabe T., Adams B.A., Numa S., Beam K.G. Repeat I of the dihydropyridine receptor is critical in determining Ca2+ channel activation kinetics. Nature. 1991;352:800–803. doi: 10.1038/352800a0. [DOI] [PubMed] [Google Scholar]
  48. Tanabe T., Mikami A., Niidome T., Numa S., Adams B.A., Beam K.G. Structure and function of voltage-dependent Ca2+ channels from muscle. Ann. NY Acad. Sci. 1993;707:81–86. doi: 10.1111/j.1749-6632.1993.tb38044.x. [DOI] [PubMed] [Google Scholar]
  49. Tsien R.W., Lipscombe D., Madison D.V., Bley K.R., Fox A.P. Multiple types of neuronal Ca2+ channels and their selective modulation. Trends Neurosci. 1988;11:431–438. doi: 10.1016/0166-2236(88)90194-4. [DOI] [PubMed] [Google Scholar]
  50. Wei X., Neely A., Lacerda A.E., Olcese R., Stefani E., Perez-Reyes E., Birnbaumer L. Modification of Ca2+channel activity by deletions at the carboxyl terminus of the cardiac α1 subunit. J. Biol. Chem. 1994;269:1635–1640. [PubMed] [Google Scholar]
  51. Zhang J.F., Randall A.D., Ellinor P.T., Horne W.A., Sather W.A., Tanabe T., Schwarz T.L., Tsien R.W. Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology. 1993;32:1075–1088. doi: 10.1016/0028-3908(93)90003-l. [DOI] [PubMed] [Google Scholar]
  52. Zühlke R.D., Pitt G.S., Tsien R.W., Reuter H. Ca2+-sensitive inactivation and facilitation of L-type Ca2+ channels both depend on specific amino acid residues in a consensus calmodulin-binding motif in the α1C subunit. J. Biol. Chem. 2000;275:21121–21129. doi: 10.1074/jbc.M002986200. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of General Physiology are provided here courtesy of The Rockefeller University Press

RESOURCES